Filing Details
- Accession Number:
- 0001110803-14-000262
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-30 18:56:02
- Reporting Period:
- 2014-07-29
- Filing Date:
- 2014-07-30
- Accepted Time:
- 2014-07-30 18:56:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008891 | Blaine A Bowman | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-29 | 5,000 | $14.09 | 17,722 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-29 | 3,400 | $166.55 | 14,322 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-29 | 1,000 | $167.23 | 13,322 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-29 | 600 | $168.30 | 12,722 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-07-29 | 5,000 | $0.00 | 5,000 | $14.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,456 | 2006-10-14 | 2016-10-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 670 | Indirect | by Partnership |
| Common Stock | 198 | Indirect | by Trust |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,400 shares sold ranging from $165.80 to $166.78 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,000 shares sold ranging from $166.83 to $167.79 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 600 shares sold ranging from $167.91 to $168.89 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
